Glisoxepide is an orally active, non-selective K(ATP) channel blocker with antihyperglycemic activity and cardiovascular regulatory effects; it inhibits bile acid uptake in isolated rat hepatocytes and noncompetitively inhibits cholate uptake with a Ki of 200 μM.